CSX CORP
For the period ended Sep 30, 2026. Filed Oct 21, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Oct 21, 2026
CSX$51.08+1.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Cash Flow Statements (Unaudited)
| Nine Months | ||
|---|---|---|
| 2026 | 2025 | |
| OPERATING ACTIVITIES | ||
| Net Earnings | $2,861 | $2,169 |
| Adjustments to Reconcile Net Earnings to Net Cash Provided by Operating Activities: | ||
| Depreciation and Amortization | 1,239 | 1,276 |
| Deferred Income Taxes | 115 | 143 |
| Goodwill Impairment | — | 164 |
| Other Operating Activities | (128) | (58) |
| Changes in Operating Assets and Liabilities: | ||
| Accounts Receivable | (196) | (30) |
| Other Current Assets | 64 | (32) |
| Accounts Payable | 67 | 36 |
| Income and Other Taxes Payable | 86 | (508) |
| Other Current Liabilities | 108 | 67 |
| Net Cash Provided by Operating Activities | 4,216 | 3,227 |
| INVESTING ACTIVITIES | ||
| Property Additions | (1,712) | (2,225) |
| Purchases of Short-Term Investments | (515) | — |
| Proceeds from Sales of Short-term Investments | 153 | 72 |
| Proceeds and Advances from Property Dispositions | 144 | 64 |
| Business Acquisition, Net of Cash Acquired | — | (15) |
| Other Investing Activities | 23 | (41) |
| Net Cash Used In Investing Activities | (1,907) | (2,145) |
| FINANCING ACTIVITIES | ||
| Shares Repurchased | (1,061) | (1,284) |
| Dividends Paid | (779) | (730) |
| Long-term Debt Repaid (Note 7) | (10) | (12) |
| Long-term Debt Issued (Note 7) | — | 600 |
| Other Financing Activities | 94 | 23 |
| Net Cash Used in Financing Activities | (1,756) | (1,403) |
| Net Increase (Decrease) in Cash and Cash Equivalents | 553 | (321) |
| CASH AND CASH EQUIVALENTS | ||
| Cash and Cash Equivalents at Beginning of Period | 670 | 933 |
| Cash and Cash Equivalents at End of Period | $1,223 | $612 |
Certain prior year data has been reclassified to conform to the current presentation.
CSX Q3 2026 Form 10-Q p.5
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.